Keywords
Hertfordshire, Cohort Study, Epidemiology, Ageing, Musculoskeletal, Lifecourse
Hertfordshire, Cohort Study, Epidemiology, Ageing, Musculoskeletal, Lifecourse
In the 1980s, ecological studies showed that death rates from heart disease in the 212 local authority areas of England and Wales during 1968–78 were correlated with infant mortality rates in those areas in the early part of the 20th century1. This raised the possibility that environmental influences acting during the fetal and infant stages of development might increase risk of cardiovascular disease in later life.
However, stronger evidence from a more robust epidemiological study design was required. The discovery of a large set of birth records for people born in Hertfordshire during the first half of the twentieth century provided an opportunity for the MRC Environmental Epidemiology Unit (MRC EEU) to establish a cohort study in which the early origins of disease in later life could be explored.
In 1911, a team of midwives and nurses was assembled in Hertfordshire with the aim of improving the health of children in the county. Midwives attended women during childbirth and health visitors routinely visited the child throughout infancy and childhood; weight at birth and one year of age, method of infant feeding, illnesses, and developmental milestones were all recorded. The information (Table 1) was transcribed into ledgers (Figure 1) at the County Health Department in Hertford. The ledgers cover almost all births in Hertfordshire from 1911 until the NHS was formed in 1948.
The MRC EEU computerised the Hertfordshire ledgers and traced the cohort by linkage with the National Health Service Central Register (NHSCR). A mortality study of 15,000 men and women born between 1911–30 showed that lower weight at birth and one year of age was associated with increased risk of death from cardiovascular disease by 75 years of age2. Subsequently, numerous detailed physiological studies were conducted among community dwelling men and women born in Hertfordshire between 1920–30 and still living there in the early 1990s. Small size in early life was associated with greater risk of cardiometabolic disease3–5, osteoporosis6 and sarcopenia (the loss of muscle mass, strength and function with age)7 in later life. Collectively these studies contributed to the “developmental origins” hypothesis which suggests that the nourishment a baby receives in utero, and its development in infancy and early childhood, determine its risk of disease in later life8.
These early studies were important for establishing relationships between the early environment and physiological markers of disease, but they lacked detailed information on adult anthropometry and diet, and the men and women born 1920–30 were becoming frail and unable to take part in further studies. A second (younger) cohort, in whom the work could be continued, was therefore recruited between 1998–2004. During this time Professor Cyrus Cooper became Hertfordshire Cohort Study (HCS) principal investigator and the MRC EEU was reconfigured as the MRC Lifecourse Epidemiology Unit (LEU), a University Unit Partnership between the MRC and the University of Southampton.
The younger cohort comprises 3000 men and women born between 1931 and 1939 who were traced following the model of the early studies. These are the people to whom the term ‘The Hertfordshire Cohort’ specifically applies. The remainder of this paper applies only to them, unless otherwise stated.
The principal objective of the HCS is to evaluate interactions between the intra-uterine and early postnatal environment, adult diet and lifestyle, and genetics, in the aetiology of chronic disorders of ageing (osteoporosis, osteoarthritis, sarcopenia, obesity, cardiometabolic disease and type II diabetes mellitus). The study aims to place these interactions within a life-course model for disease pathogenesis, and to characterise the physiological mechanisms underlying the pathways to these chronic disorders.
The baseline recruitment of HCS participants has been described in detail previously9; key stages in the process are shown in Figure 2. In brief, the ledgers contained records for 42974 births in Hertfordshire between 1931 and 1939; the National Health Service Central Register (NHSCR) in Southport (now part of NHS Digital) traced 8650 men and women who were still alive in Hertfordshire in 1998. Permission to contact 6099 men and women by letter was obtained from their GPs and 3225 (53%) agreed to a home interview with a trained research nurse. 2997 (93%) men and women subsequently attended a clinic for detailed physiological investigations. The baseline HCS fieldwork was county-wide but conducted in phases by geographical area and gender. 966 (68%) of the 1412 men and women who attended clinic in East Hertfordshire also underwent a Dual-energy X-ray Absorptiometry (DXA) bone scan and knee radiography. An overview of the data collected at the HCS baseline home interviews and clinics is provided in Table 2.
The HCS baseline investigations had ethical approval from the Hertfordshire and Bedfordshire Local Research Ethics Committee and all subjects gave written informed consent. All interviews and physiological investigations were carried out according to strict protocols and studies of within- and between-observer variation were conducted at regular intervals during fieldwork to ensure comparability of measurements obtained over time. Data were collected, anonymised, processed and stored in accordance with contemporary data protection regulations. Participants are free to withdraw from the study at any time.
Since their first contact in 1998–2004, HCS cohort members have generously agreed to take part in various follow-up postal questionnaires, face-to-face interviews, clinics, intervention studies, and focus groups (see Figure 2). With their consent, data on hospital admissions experienced by the cohort members across a decade have been obtained from NHS Digital10, and cohort members remain flagged on the National Health Service Central Register for ongoing notification of mortality. Ethical approval was obtained for all elements of the study at the time they were conducted.
Table 3 to Table 11 describe the scientific objective and methodology of each HCS follow-up study and detail key data availability. Taken together, the HCS datasets provide a rich, detailed and longitudinal characterisation of the sociodemographic, lifestyle, medical and biological attributes of a contemporary group of community-dwelling older men and women in the UK.
HCS is a particularly valuable resource for research that aims to identify lifecourse influences on ageing. Longitudinal measurements are available for a range of markers of disease and for potential predictor and confounding variables. The study has been pioneering in its uptake of techniques not previously used in epidemiology to characterise health (for example High Resolution peripheral Quantitative Computed Tomography (HR pQCT) scanning and muscle biopsy) and has sought to maximise the value of routinely collected data through record linkage.
The following sections outline key publications in the areas of osteoporosis, osteoarthritis, sarcopenia and diet.
Osteoporosis is the most common metabolic bone disease affecting older people; almost one in two women and one in five men aged 50 years will have an osteoporotic fracture in their remaining lifetime11. The LEU is a renowned contributor to research on osteoporosis, in part because of the wealth of data collected in HCS (Table 2–Table 12). Estimates of bone mineral density (BMD) and bone mineral content (BMC) have been obtained by DXA; estimates of bone strength (including strength strain index (SSI)), cortical bone and trabecular bone by peripheral Quantitative Computed Tomography (pQCT); and ‘virtual bone biopsies’ by HR pQCT. Few other cohorts have characterised bone in such detail.
Objective: | To examine whether the impact of aerobic exercise training on metabolic risk, physical fitness and function, and body composition differs with respect to growth in early life. |
Methodology: | Randomised controlled trial conducted in collaboration with University of Cambridge. 100 HCS participants randomised to exercise-intervention (12 week gym training programme) or placebo (habitual physical activity) arm of the trial. Assessments conducted at HPAT baseline and 12 week follow-up20. |
Key data availability: | |
• Blood pressure (Omron recorder) • Standard 12-lead electrocardiography • Two-hour timed 75g oral glucose tolerance test: Glucose and insulin 30’ and 120’ post load • Venous blood samples after overnight fast: Glucose Insulin Liver and lipid profiles C-peptide • Height; weight; waist and hip circumferences • Whole body DXA scan (Lunar Prodigy Advanced scanner) • Ultrasound measurement of body composition (LOGIQ Book XP device) • MRI scans of liver and muscle composition (Siemens 3T Tim Trio scanner) • Sub-maximal cycle ergometry exercise test (heart rate, energy expenditure and oxygen consumption) • 7-day Actiheart physical activity monitoring • Physical activity questionnaire (modified EPAQ2) • Grip strength (Jamar hand-grip dynamometer) • Timed 6m up-and-go test and 3m walk • Chair rises • Timed one-legged stand |
Objective: | To explore whether small size at birth is associated with cellular changes in human skeletal muscle that persist into adult life and have adverse consequences for muscle ageing in terms of muscle mass, lower strength and impaired metabolism. |
Methodology: | Home visit followed by detailed clinical assessments during a day visit at the Wellcome Trust Clinical Research Facility, Southampton General Hospital21. |
Key data availability: | |
• Cigarette smoking • Alcohol consumption • Short food frequency questionnaire (HSSe only) • Falls • Strawbridge frailty score • Fried frailty components • Townsend disability scale • Physical activity questionnaire • SF-36 health related quality of life • Co-morbidity • Current medications • Cognitive function (AH4 intelligence quotient, Mill Hill vocabulary test) • Day and night salivary stress hormones • Venous blood samples after overnight fast: glucose insulin HbA1c hormonal, inflammatory and DNA analyses • Biopsy of the vastus lateralis muscle using a Weil Blakesley conchotome • Immunohistochemical analysis of muscle: myofibre type, number, density and area • Muscle tissue stored at -80C for gene expression studies • DXA scan to quantify regional and total lean mass, fat mass and bone mineral content (Hologic Discovery) • Sub-maximal cycle ergometry exercise test (heart rate, energy expenditure and oxygen consumption) • Height; weight; waist, hip, mid upper arm, and thigh circumferences • Triceps, biceps, subscapular and suprailiac skinfold thicknesses (Crymych callipers) • Blood pressure (DASH 3000 device) • ECG • Grip strength (Jamar hand-grip dynamometer) • Timed 6m up-and-go test and 3m walk • Chair rises • Timed one-legged stand • 7-day wrist-worn Geneactiv physical activity monitoring |
Objective: | To identify risk factors for, and consequences of, osteoarthritis (OA) for individuals and society and to explore cross-country differences in these patterns. |
Methodology: | Collaborative study with five other centres in Germany, Holland, Sweden, Spain and Italy30. HCS fieldwork conducted by a nurse home visit followed by x-rays at Hertford County Hospital. HCS EPOSA participants were recruited from men and women who had previously participated in the musculoskeletal follow-up study. |
Key data availability: | |
• Osteoarthritis questionnaire (affected sites, functional limitation, clinical procedures, joint replacement surgery) • WOMAC hip and knee pain, stiffness and function scores • Oxford hip and knee pain and limitation scores • Auscan pain, stiffness and function scores • EuroQoL EQ-5D quality of life (mobility, self care, activities, pain, anxiety, health) • Use of assistive devices • Falls • Fractures • Strawbridge frailty score • Fried frailty components • Townsend disability scale • Current medications • Cigarette smoking • Alcohol consumption • Household composition • Housing tenure • Short food frequency questionnaire • Nutrient intake from dietary supplements • Longitudinal Ageing Study Amsterdam physical activity questionnaire (LAPAQ) • Health service use (hospitalisations, operations, GP and health professional consultations) • Formal and informal home care • Mobility problems • Co-morbidity • Mini mental state examination (MMSE) • Height; weight; waist, hip and calf circumferences • Clinical hand examination for pain, • swelling and tenderness • Clinical hip and knee examination for flexion, rotation, pain, swelling and tenderness • Timed balance tests • Timed 6m up-and-go test and 8 foot walk • Chair rises • Grip strength (Jamar hand-grip dynamometer) • Lubben social network score • Pearlin mastery scale score • Maastricht Social Participation Profile (MSPP) scores • Pittsburgh Sleep Quality questionnaire (sleep duration, difficulties, disturbances) • Anxiety and depression (HAD) scores • 14-day pain calendar • X-ray of hip; antero-posterior and lateral x-rays of both knees (Kellgren/Lawrence grading scores, osteophytes, joint space and sclerosis) |
Predictors of osteoporosis. The Health Visitors’ records that are uniquely available in HCS have enabled investigation of the early-life origins of osteoporosis. Studies using DXA showed an increase in adult BMC with rising weight at birth, and more strongly, with weight at one year. Models that also included weight in adulthood showed impacts accruing from each time-point, with greater contributions of early growth to BMC than to BMD12. In addition, growth during the first year was shown to alter the geometry of the adult hip13. Studies using pQCT showed that bone strength was similarly related to early weights14.
Risk of osteoporosis attributable to lifestyle has also been investigated in this cohort. While no social patterning has been observed15, nor any relationship found between cigarette smoking, alcohol use, or physical activity and either BMC or BMD16, alcohol has been associated with less radial cortical and trabecular bone in men and less tibial trabecular bone in women17. Clustering of risk factors (physical activity, diet, alcohol consumption, smoking behaviour, grip strength, personal and family interactions, comorbidities) has been found to increase the risk of low BMD in women18. Also in women, pQCT scans have shown that having a ‘healthier’ diet (characterised by greater consumption of fruit, vegetables and wholegrain cereals) is associated with increased bone area on pQCT scanning19. Some lifestyle risk factors appear to interact with early life factors to influence osteoporosis risk, for example, in men, having a low birth weight and being a current smoker increased the risk of low femoral BMD16.
Osteoporosis and comorbidity. HCS has provided valuable insight into the interplay between osteoporosis and other chronic conditions. For example, in the case of cardiometabolic disease, analyses have shown that: BMD is associated with serum triglycerides and HDL22; higher BMI is associated with lower 25(OH) vitamin D23; arterial calcification affects the structure of cortical and trabecular bone in women, but not in men24; hyperinsulinemia influences BMD through BMI25; and the associations between lean and fat mass and bone microarchitecture differ26. In the case of chronic inflammation in later life (inflammaging), HCS has shown that an elevated inflammatory state is associated with reduced BMD at baseline and with an accelerated rate of decline over time27. Relationships between muscle and bone health are discussed in the section on sarcopenia that follows.
Outcomes of osteoporosis. The primary outcome of osteoporosis is fracture, which carries high personal and societal costs. Risk of fracture has been elucidated in HCS, showing, for example, that history of falls adds to clinical risk factors and low BMD as a risk factor for fracture28. Research using pQCT scans has shown that in women, cortical radial thickness and area, and tibial cortical area and density, are associated with adult fracture risk, and in men tibial SSI is associated with adult fracture risk29. Finally, cluster analysis of bone microarchitecture from HR pQCT has demonstrated two separate phenotypes associated with high fracture risk31.
OA is the most common joint disease affecting older people32. It is an important element of the research programme of the LEU and its incorporated Arthritis Research UK MRC Centre for Musculoskeletal Health and Work. In HCS, radiographic, clinical and self-reported markers of OA have been collected at multiple time points (Table 2–Table 12).
Descriptive epidemiology. HCS data have been used to show that the method of ascertainment of OA status affects both its calculated prevalence33 and the demographic characteristics with which it is associated34. For example, prevalence of knee OA ranged from 18% for clinically diagnosed disease through 21% for self-reported disease to 42% when the diagnostic criteria were radiographic; with higher specificity and lower sensitivity for clinical and self-reported OA than for radiographically determined disease33. Further work utilising data for multiple methods of ascertainment showed that in the presence of radiographically determined disease in the knee, signs and symptoms differed dependent on the bones involved, tibiofemoral OA being associated with both signs and symptoms, and patellofemoral OA only with clinical signs35.
Predictors of OA. Results from this study have demonstrated that growth before birth and in the first year both affect the likelihood of developing OA in later life36. Specifically, an increase in number of osteophytes on hip radiographs has been associated with low birthweight and the number on knee radiographs with low weight at 1 year. An increased prevalence of clinical OA at the hand was also seen in those whose weight at 1 was low. Conversely, rheumatoid arthritis was not associated with early weight37. The role of biochemical markers of bone in the aetiology of OA has also been investigated, finding that CTX-II and glucosyl-galactosyl-pyridinoline were associated with both osteophyte score and joint-space narrowing, whist CTX1 and osteocalcin were not38.
Outcomes of OA. The consequences of OA include an increase in the impact of objectively measured neighbourhood problems on participants’ physical activity39 and quality of life40. Pain is an important symptom of OA which, in HCS and other EPOSA cohorts, has been found to fully explain the association of OA with objectively measured (but not with self-reported) physical function41. This suggests that individuals consider factors other than pain (e.g. comorbidity) in making an assessment of their physical function.
Table 2–Table 12 show that HCS has collected a wealth of markers of the mass, strength, function and morphology of muscle. Together, these have enabled a rich body of research on the predictors and consequences of sarcopenia.
Descriptive epidemiology. Sarcopenia may be defined by one or more of the markers collected in HCS, inter-relationships between which have been explored in detail42,43. The prevalence of sarcopenia across HCS, estimated according to European Working Group for Sarcopenia in Older People (EWGSOP) guidelines, but with lean mass estimated by skinfold measurements, was 4.6% in men and 7.9% in women44. For subgroups of HCS in which imaging and anthropometric data coexist, estimates of prevalence have been calculated according to more than one operational definition of sarcopenia (EWGSOP; International Working Group on Sarcopenia; Foundation for the National Institutes of Health sarcopenia project; dysmobility syndrome), enabling the methods to be compared directly44,45. Late-life declines in muscle mass as well as strength have been observed using data from two of the time points shown on Figure 2 (MSFU and EPOSA); these data suggest that muscle mass declines less rapidly than strength or function46.
Predictors of sarcopenia. The early-life origins of sarcopenia have been investigated using data from the Health Visitors’ records. Weights at birth and one year of age have been related to adult anthropometry, showing that whilst BMI and lean mass rise with birthweight and with weight at one, fat mass has associations only with the latter47. This suggests that whilst the prenatal environment affects lean mass, the postnatal environment is more influential in the development of adult adiposity. Direct measures of muscle size from pQCT scanning have confirmed that birthweight is associated with muscle area in the calf and forearm48, whilst biopsies showed that smaller babies have lower total myofibre scores (kg/mm2) than those who were bigger at birth49. Grip strength was more strongly associated with birth weight than with growth during the first year of life in HCS participants50. This again suggests that sarcopenia has primarily pre- rather than post-natal origins, though there is some evidence to link breast feeding during infancy with increased grip strength51. A systematic review and meta-analysis of work in HCS and other cohorts showed that the positive relationship between birth weight and muscle strength exists across the lifecourse52.
The effects of adult lifestyle on risk of sarcopenia have also been investigated. First, to examine the role of diet, associations of grip strength with specific nutrients, individual foods and dietary patterns were studied. Healthier diets were associated with higher grip strength, although the strongest association was with more frequent consumption of oily fish53. Physical activity in old age, objectively measured by accelerometry, was found to be associated with decreased risk of EWGSOP sarcopenia and improved physical function, though not with grip strength54. Grip strength was not associated with lifetime occupational exposure to physically demanding activities55, a somewhat surprising finding in the light of evidence of social patterning in sarcopenia56. The role of adult heath in causal paths to sarcopenia has also been investigated, identifying multimorbidity57, inflammaging58, and some59, but not all60, cardiovascular drugs as important influences.
Outcomes of sarcopenia. Sarcopenia has profound consequences for health and wellbeing in later life and is associated in HCS with increased risk of hospital admission61. Changes in ageing muscle have been shown to contribute to the metabolic syndrome and all its components62; to self-rated health and health-related quality of life63; and to bone mineral content64. Together with strong independent relationships between muscle and bone size/strength65, this latter finding supports the existence of a muscle/bone unit and provides some insight into the mechanisms that underlie it.
Determinants of diet quality. The HCS has described marked differences in dietary choices in later life. For example, healthier diets have been found to be associated with being female, reporting a non-manual social class, and with being a non-smoker66. Psychological and social factors have important influences67, greater involvement in social activities being associated with slower declines in diet quality68. In addition, a relationship has been described between infant feeding and health behaviours in later life, such that people who were breastfed as infants were more likely to have healthier diets69.
Outcomes of diet quality. Our studies have described links between differences in nutrient intake and physical functioning in older women70, and shown that there is a graded increase in the prevalence of poor physical functioning in older adults as the number of risk factors (from obesity, smoking and poor diet) increases71. Less healthy diets also contribute to risk of hospital admission72. Additionally, higher processed meat consumption and antioxidant intake have been related to poorer lung function in HCS73, while low dietary antioxidants were also associated with poorer glucose tolerance74.
Methodology. Assessment of diet in older populations can be burdensome. In HCS, a short food frequency questionnaire was therefore developed and validated to assess compliance with a healthy dietary pattern in older community-dwelling adults75.
The Medical Research Council76 and the Wellcome Trust77 have advocated for the scientific and interdisciplinary potential of cohorts to be enhanced through linkage to routine health records and administrative datasets. Such linkage is particularly valuable in an ageing cohort like HCS, where attrition may lead to bias if data collection requires participant contact. Successful linkage has been achieved in HCS with mortality and Hospital Episode Statistics (HES) data (Table 12), though difficulties persist over data access due to constantly changing regulations.
In total, the 1911 to 1939 Hertfordshire birth cohort comprises 37 000 men and women, 7916 of whom had died by the end of 1999. Risk of death from circulatory disease was lower among men and women who were heavier at birth. Women who were heavier at birth also had lower risk of death from pneumonia, injury, diabetes, and musculoskeletal disease78.
HCS was one of the first English cohorts to link with HES data and produced early evidence on the descriptive epidemiology of hospital admissions among older individuals10. Such individual level data contrast with published statistics, which are at the population level. A novel methodology was developed to explore risk factors for admission in these multiple-failure survival data79, demonstrating links between admission and grip strength61, and showing that poor lifestyle risk factors have a cumulative effect on likelihood of admission72.
Since its inception, HCS has studied the genetics of musculoskeletal ageing. The scientific approach has evolved across the years, alongside dramatic changes in the technologies available to characterise the genome. Early studies of genetic influences on adult disease in HCS considered the role of single nucleotide polymorphisms (SNPs) and their specific interaction with early life phenotypes as predictors of muscle and bone health in later life80,81. Haplotype studies followed81–83, and more recently HCS has been an important contributor to many genome wide association studies conducted by worldwide consortia84,85. Finally, in the Hertfordshire Sarcopenia Study (HSS), participation in the industry funded MEMOSA (Multi-Ethnic MOlecular determinants of human SArcopenia) collaboration has permitted cutting edge scientific techniques such as deep sequencing of RNA as well as high coverage methylation arrays to be completed in a subset of participants. Furthermore, muscle cells obtained from biopsies of older men and women have been cultured in vitro providing a biobank that together with RNA and methylation data, will permit the investigation of genetic and epigenetic pathways in musculoskeletal ageing. This is an exciting area for future research in HCS
The HCS research group has a long and successful history of conducting collaborative research; principal local, national and international collaborators are detailed in Table 13. The nature of HCS collaborations varies widely, all are welcomed by the HCS research team. For example, bespoke results from statistical analyses and/or datasets have been provided to collaborators (ranging from PhD students to established research groups and international consortia) for inclusion in systematic reviews and meta-analyses. In other instances, students have visited the MRC LEU and worked alongside the HCS research team to conduct a specific sub-study or to run statistical analyses and draft a paper for publication. Another mode of collaboration is the provision of biological samples (e.g. plasma or DNA) to research groups and their laboratories; the information that they generate is returned to the HCS research team for inclusion in the master HCS databases. The resulting enhanced database is either analysed by HCS statisticians or released to the collaborators for them to analyse; either approach results in a jointly authored peer reviewed publication. Finally, the HCS research team may collaborate by submitting an ethics application jointly with a research group and conducting the study together; for example, the HPAT physical activity trial, the wellbeing follow-up study, and the VIBE study were conducted in collaboration with the MRC Epidemiology Unit (University of Cambridge), the MRC Unit for Lifelong Health and Ageing (at UCL) and the University of Bristol, respectively (see Figure 2 for timeline of HCS sub-studies).
HCS is a flagship cohort that has demonstrated lifecourse influences on musculoskeletal health in later life. All of the information collected to date is extensively documented and carefully curated and, as evidenced by a broad body of collaborators and over 250 peer-reviewed publications to date, the cohort will continue to be an invaluable resource for national and international research on the lifecourse determinants of musculoskeletal health in later life. Cohort members remain flagged with NHS Digital for ongoing notification of death, and further extracts of HES data would enable long-term follow-up of morbidity for the whole cohort (subject to funding and permission to access data).
Two examples of future research areas in HCS are: first, development of lifecourse interventions to promote maintenance of health, and slow loss of function, of the musculoskeletal system in later life; and second, investigation of the mechanisms that explain how early life environment influences health in later life.
The ambition to develop lifecourse interventions to maintain the health of the musculoskeletal system in later life is a natural progression from the epidemiological studies that have been conducted in HCS and other cohorts to date. Diet and physical activity are now well established as key influences on musculoskeletal health in later life, but research in HCS and elsewhere has shown that lifestyle risk factors cluster together to impact on physical function in later life71. Therefore, any lifestyle based intervention strategy would be well advised to adopt a holistic whole-person approach. Accordingly, the HCS research team’s objective is to develop and test the feasibility of a combined healthy conversation and physical activity intervention to promote muscle mass, strength and function in later life with the ultimate aim of preventing falls and fractures. If this is successful, the intervention will be implemented more widely and its efficacy evaluated.
Epigenetics is an important area for research that seeks to move from epidemiological associations to identification of the mechanisms that underpin early life influences on health in later life. Epigenetics is the study of changes in organisms caused by modification of gene expression rather than alteration of the genetic code itself. For example, in HSS and HSSe participants, we are in the early phase of investigating whether the expression of genes associated with cellular pathways is altered during muscle ageing and how this contributes to sarcopenia. We are also studying genes associated with inflammation, mitochondrial function and the regulation of muscle growth, and taking the novel approach of investigating epigenetic pathways by studying DNA methylation markers in muscle tissue and also in cultured primary skeletal muscle cells. The results from this work will give us clues about how sarcopenia begins, progresses, and what can be done to prevent or treat it.
Epigenetics underpins the ambition to expand HCS to an intergenerational study. The theory of transgenerational epigenetics implies that maternal environment during pregnancy transmits to offspring and affects their subsequent gene expression86. An intergenerational study in HCS is a very special opportunity to investigate how epigenetic expression transmits across generations, and indeed to explore commonalities and differences in musculoskeletal health across generations. To date, more than 1,000 members of the HCS cohort (the ‘F0 generation’) have provided us with the names and contact details of their children (the ‘F1 generation’) and grandchildren (the ‘F2 generation’). We are now in the process of recruiting these children and grandchildren to an HCS three generation cohort (HCS 3G); in the first instance we are seeking their consent to contact them in the future with invitations to participate in specific studies as they are planned. To date, more than 700 children and grandchildren have agreed to be members of the HCS 3G study. Following on in the tradition of their parents or grandparents who have participated so generously in HCS, these people will make an important contribution to our understanding of lifecourse and intergenerational influences on musculoskeletal health.
Hospital Episode Statistics and mortality data were obtained from NHS Digital under Data Sharing Agreements numbered 148284 and 343023; but cannot be made openly available for ethical reasons. HCS data collected directly by the MRC LEU are accessible via collaboration with the HCS research group as described above. Initial enquires should be made to Professor Cyrus Cooper (Principal Investigator, e-mail: cc@mrc.soton.ac.uk). Potential collaborators will be sent a collaborators’ pack and asked to submit a detailed study proposal to the HCS Steering Group; applications will be reviewed at the first available steering group meeting (held three times annually).
HCS is supported by the Medical Research Council University Unit Partnership grant number MRC_MC_UP_A620_1014.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
We thank the men and women who have participated in the Hertfordshire studies, the Hertfordshire General Practitioners, and all the nurses and doctors who have conducted HCS fieldwork over many years.
The Hertfordshire Cohort Study research group currently comprises: Gregorio Bevilacqua; Ilse Bloom; Michael Clynes; Ken Cox; Vanessa Cox; Nicholas Fuggle; Catharine Gale; John Holloway; Karen Jameson; Camille Parsons; Harnish Patel; Kate Ward; Leo Westbury.
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Is the topic of the review discussed comprehensively in the context of the current literature?
Yes
Are all factual statements correct and adequately supported by citations?
Yes
Is the review written in accessible language?
Yes
Are the conclusions drawn appropriate in the context of the current research literature?
Yes
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Cardiovascular and nutritional epidemiology and health promotion
Is the topic of the review discussed comprehensively in the context of the current literature?
Yes
Are all factual statements correct and adequately supported by citations?
Yes
Is the review written in accessible language?
Yes
Are the conclusions drawn appropriate in the context of the current research literature?
Yes
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Ageing, life course perspective, anthropometry
Is the topic of the review discussed comprehensively in the context of the current literature?
Yes
Are all factual statements correct and adequately supported by citations?
Yes
Is the review written in accessible language?
Yes
Are the conclusions drawn appropriate in the context of the current research literature?
Yes
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Developmental Origins of Health and Disease
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | |||
---|---|---|---|
1 | 2 | 3 | |
Version 1 21 Jan 19 |
read | read | read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)